Machine Learning for Diagnosis of Occlusive MI in LBBB Patients (AI-LBBB)
Development of a Machine Learning Model for the Diagnosis of Occlusive Myocardial Infarction in the Setting of Left Bundle Branch Block
This study investigates a new way to diagnose severe heart attacks in patients who have a specific electrical heart pattern called a Left Bundle Branch Block (LBBB). When patients present to the emergency department with chest pain, doctors routinely perform an electrocardiogram (ECG) to check for a heart attack. However, the presence of an LBBB can alter the heart's electrical signals on the ECG, effectively masking or hiding the typical signs of an ongoing acute coronary occlusion (a completely blocked artery). This making it highly challenging for emergency physicians to make an accurate and rapid diagnosis.
The primary purpose of this prospective and observational research is to develop and evaluate an artificial intelligence/machine learning (ML) model that can analyze digital 12-lead ECG signals to accurately predict a true blocked coronary artery in patients with LBBB. The machine learning model will analyze raw digital ECG waveforms to detect subtle, microscopic patterns that might be missed by the human eye.
To confirm the accuracy of the model, its predictions will be compared directly with invasive coronary angiography results, which is the gold standard reference method used to visualize blocked vessels. Additionally, the study aims to evaluate if the model can differentiate between a true heart attack caused by a blocked artery (Type 1 MI) and other non-occlusive conditions that cause elevated heart enzymes (Type 2 MI). Ultimately, the investigators intend to determine whether integrating this machine learning tool into emergency care can safely reduce the rate of unnecessary emergency invasive procedures for patients who do not have a true coronary blockage.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienorte
-
-
Karatay
-
Konya, Karatay, Türkei (türkiye), 42100
- Rekrutierung
- Konya City Hospital
-
Kontakt:
- Ahmet Gumus, MD, Emergency Medicine Residen
- Telefonnummer: +905547957490
- E-Mail: ahmetgms88@gmail.com
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- Patients aged 18 years and older who present to the emergency department. Patients presenting with acute ischemic chest pain or clinical ischemia-equivalent symptoms (such as acute dyspnea, unexplained diaphoresis, or syncope).
Patients with a confirmed Left Bundle Branch Block (LBBB) on their initial 12-lead electrocardiogram (ECG), which can be either newly developed or known/chronic.
Patients who undergo invasive coronary angiography during their index hospital admission.
Patients or their legally authorized representatives who provide written informed consent to participate in the study.
Exclusion Criteria:
- Patients under the age of 18. Pregnant or lactating women. Patients with poor-quality or uninterpretable digital ECG recordings due to severe artifact, missing leads, or technical errors.
Patients who develop cardiopulmonary arrest before an initial diagnostic 12-lead ECG can be obtained in the emergency department.
Patients transferred from another healthcare facility who have already undergone coronary angiography or revascularization.
Patients who decline to participate or refuse to provide written informed consent.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Diagnostic Performance for Occlusive Acute Myocardial Infarction
Zeitfenster: Within the emergency department index visit (typically within 24 hours of presentation).
|
Evaluation of the developed machine learning model's diagnostic performance in predicting angiographically proven acute coronary occlusion (defined as TIMI 0-1 flow or equivalent true occlusion during catheterization).
The primary metrics to evaluate this outcome will include the Area Under the Receiver Operating Characteristic (ROC) Curve (AUC), Sensitivity, Specificity, Positive Predictive Value (PPV), and Negative Predictive Value (NPV).
|
Within the emergency department index visit (typically within 24 hours of presentation).
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Title: Differentiation Performance Between Type 1 MI and Type 2 MI
Zeitfenster: Within the hospital stay (up to 7 days).
|
Evaluation of the machine learning model's performance (measured by AUC, sensitivity, and specificity) to distinguish between acute coronary occlusion (Type 1 MI) and non-occlusive ischemic myocardial injury or supply-demand mismatch presenting with elevated cardiac troponin (Type 2 MI).
|
Within the hospital stay (up to 7 days).
|
|
Projected Reduction Rate of Unnecessary Angiographies
Zeitfenster: Calculated at the study completion
|
Simulation and post-hoc analysis to quantify the potential relative reduction in the rate of emergency invasive coronary angiographies among LBBB patients without true coronary occlusion by applying the model's diagnostic probability scores.
|
Calculated at the study completion
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
- Erkrankung des Herzleitungssystems
- Schmerzen
- Neurologische Manifestationen
- Gefäßerkrankungen
- Herz-Kreislauf-Erkrankungen
- Pathologische Prozesse
- Herzkrankheiten
- Arrhythmien, Herz
- Infarkt
- Nekrose
- Herzblock
- Embolie und Thrombose
- Koronare Krankheit
- Myokardischämie
- Ischämie
- Pathologische Zustände, Anzeichen und Symptome
- Anzeichen und Symptome
- Thrombose
- Herzinfarkt
- Bundle-Zweig-Block
- Brustschmerzen
- Koronare Okklusion
Andere Studien-ID-Nummern
- 2026/133
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .